v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating Expenses:    
Research and development $ 37,187 $ 41,676
General and administrative 10,612 12,290
Total operating expenses 47,799 53,966
Loss from operations (47,799) (53,966)
Other income (expense):    
Grant income 23,406 19,549
Other income, net 919 666
Interest expense (13) (25)
Loss on currency translation from liquidation of subsidiary   (195)
Total other income, net 24,312 19,995
Net loss (23,487) (33,971)
Foreign currency translation adjustment, including reclassifications   195
Total comprehensive loss $ (23,487) $ (33,776)
Net loss per share:    
Net loss per share, basic (in dollars per share) $ (0.32) $ (0.86)
Net loss per share, diluted (in dollars per share) $ (0.32) $ (0.86)
Weighted-average common shares outstanding:    
Weighted-average common shares outstanding, basic (in shares) 72,766,983 39,730,148
Weighted-average common shares outstanding, diluted (in shares) 72,766,983 39,730,148